D&M Co., Ltd. AI Stock Analysis
Want to see JP:189A full AI Analyst Report?
D&M Co., Ltd. (189A) AI Stock Analysis
D&M Co., Ltd.
(TSE/TYO:189A)
The score is held back primarily by weak financial quality: despite strong top-line growth and rising net income, D&M has not generated positive free cash flow since FY2022 and carries a heavy, rapidly growing debt load alongside compressing margins. Offsetting this, the stock trades at an undemanding 10.0x earnings with a 1.9% dividend yield and sits above its 50-, 100- and 200-day moving averages, indicating a positive longer-term trend, though near-term momentum has flattened. Until cash generation turns positive and leverage declines further, the risk profile keeps the overall rating around average.
D&M Co., Ltd. (189A) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 2.44B
- Dividend Yield
- 1.89%
- Average Volume (3M)
- 3,360
- Price to Earnings (P/E)
- 10.1
- Beta (1Y)
- 0.31
- Revenue Growth
- 8.02%
- EPS Growth
- 9.50%
- Country
- Japan
- Employees
- 68
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
D&M Co., Ltd. Business Overview & Revenue Model
Company Description
D & M Company Co., Ltd. engages in the provision of management support for people involved in the medical and long-term care welfare business. It offers finance and investment; consulting and business renovation; and Human Resource and outsourced ser...
D&M Co., Ltd. Financial Statement Overview
Summary
Revenue growth is impressive (¥930M in FY2022 to a projected ¥1.62B in FY2026, including 110.7% growth in the latest year) and net income has risen steadily to ¥222M. However, this expansion is debt-funded: total debt nearly doubled to ¥8.0B and debt-to-equity remains elevated at ~3.4x. Margins are compressing across the board (gross from ~69% to ~54%, EBIT from ~25% to ~17%). The weakest link is cash flow — operating cash flow has been negative in four of the last five years (¥-804M in FY2026) and free cash flow reached ¥-1.02B, signaling that reported profits are not converting into cash.
Income Statement
62PositiveBalance Sheet
35NegativeCash Flow
18Very Negative| Breakdown | TTM | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.62B | 1.62B | 1.50B | 1.19B | 1.11B | 930.45M |
| Gross Profit | 934.42M | 871.68M | 845.89M | 754.83M | 655.71M | 640.68M |
| EBITDA | 340.27M | 287.15M | 310.20M | 288.27M | 242.34M | 238.65M |
| Net Income | 240.79M | 221.89M | 220.74M | 177.37M | 171.67M | 145.69M |
Balance Sheet | ||||||
| Total Assets | 11.76B | 10.62B | 9.29B | 8.79B | 8.10B | 5.64B |
| Cash, Cash Equivalents and Short-Term Investments | 647.49M | 636.29M | 583.36M | 480.38M | 756.09M | 693.30M |
| Total Debt | 9.20B | 8.03B | 6.92B | 7.29B | 6.77B | 4.56B |
| Total Liabilities | 9.38B | 8.28B | 7.17B | 7.52B | 7.00B | 4.70B |
| Stockholders Equity | 2.38B | 2.35B | 2.12B | 1.27B | 1.10B | 937.89M |
Cash Flow | ||||||
| Free Cash Flow | -1.02B | -1.02B | -102.30M | -784.82M | -2.21B | 906.72M |
| Operating Cash Flow | -804.09M | -804.09M | -69.76M | -782.74M | -2.19B | 911.23M |
| Investing Cash Flow | -148.23M | -148.23M | -73.69M | -20.59M | 45.95M | 32.38M |
| Financing Cash Flow | 1.11B | 1.11B | 250.22M | 509.20M | 2.17B | -1.17B |
D&M Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:189A, the sentiment is Neutral. The current price of 1059.00 is below the 20-day moving average (MA) of 1060.35, below the 50-day MA of 1061.60, and above the 200-day MA of 974.17, indicating a neutral trend. The MACD of 1.01 indicates Negative momentum. The RSI at 49.77 is Neutral, neither overbought nor oversold. The STOCH value of 87.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:189A.
D&M Co., Ltd. Peers Comparison
Overall Rating
JP:606273Outperform
JP:922069.75Neutral
JP:237357Neutral
JP:189A55Neutral
JP:242555Neutral
JP:736255Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | JPY 64.01B | 14.43 | ― | 2.19% | 5.50% | 45.42% | |
| 70Neutral | JPY 3.08B | 6.39 | ― | 3.40% | 5.71% | 10.34% | |
| 57Neutral | JPY 5.21B | 18.02 | ― | 4.46% | 4.76% | -52.55% | |
| 55Neutral | JPY 2.50B | 10.07 | ― | 1.89% | 8.02% | 9.50% | |
| 55Neutral | JPY 2.50B | 28.45 | ― | 3.34% | -3.64% | -66.52% | |
| 55Neutral | JPY 1.31B | 8.14 | ― | ― | 20.92% | 135.80% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:189A | D&M Co., Ltd. | 1059.00 | 36.96 | 3.62% | |
| JP:2373 | Care Twentyone Corporation | 381.00 | -47.26 | -11.04% | |
| JP:2425 | Care Service Co., Ltd. | 659.00 | -103.11 | -13.53% | |
| JP:6062 | Charm Care Corporation | 1963.00 | 740.87 | 60.62% | |
| JP:7362 | Terminalcare Support Institute, Inc. | 856.00 | 35.04 | 4.27% | |
| JP:9220 | FB CARE SERVICE CO.,LTD. | 1265.00 | 79.62 | 6.72% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 15, 2026
